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Abstract
Identifying molecular mechanisms or therapeutic targets is typically based on large-scale cellular
analysis that measures the abundance of mRNA or protein; however, abundance does not
necessarily correlate with activity. We report a method for direct large-scale quantification of
active pathways that employs a cellular array with parallel gene delivery of constructs that report
pathway activity. The reporter constructs encode luciferase, whose expression is influenced by
binding of transcription factors (TFs), which are the downstream targets of signaling pathways.
Luciferase levels are quantified by bioluminescence imaging (BLI), which allows for rapid, non-
invasive measurements. Activity profiles by BLI of 32 TFs were robust, consistent, and
reproducible, and correlated with standard cell lysis techniques. The array identified five TFs with
differential activity during phorbol-12-myristate-13-acetate (PMA)-induced differentiation of
breast cancer cells. A system for rapid, large-scale, BLI quantification of pathway activity
provides an enabling technology for mechanistic studies of cellular responses and processes.
Keywords
cellular array; transcription factor activity; bioluminescence imaging
Introduction
Activities of signaling pathways within the intracellular network determine cellular response
and signaling pathways with aberrant activity underlying many diseases (Barnes, 2006;
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Latchman, 1996; Scherzer et al., 2008; Strano et al., 2007). Methods to identify active
pathways within cells could be used to molecularly dissect the basis for normal and diseased
states and disease progression. Numerous signal transduction pathways interact to form a
complex network, whose net output determines the cellular response. The outputs of the
network or termination points of signaling pathways are transcription factors (TFs), which
directly modulate gene expression and are powerful regulators of cell function (Nebert,
2002; Orphanides and Reinberg, 2002). The potential of TFs to regulate cellular responses
was recently evidenced by the induction of pluripotent stem cells from adult fibroblasts
through the expression of four TFs (Takahashi and Yamanaka, 2006). TF activity is defined
by its ability to activate or suppress transcription as a result of sequence-specific binding to
regions that directly influence the expression of genes. The activities of TFs are commonly
measured using TF reporter vectors, which contain a TF-specific binding enhancer element
upstream of a promoter that drives the expression of a reporter protein such as firefly
luciferase. Measuring the activity of a TF through the reporter protein thus reflects the net
activity of the upstream signaling pathway.
Analysis of the complex signaling network requires large-scale cell-based assays to capture
the numerous signals within the cell that determine the response. To measure the TF
activity, a cell-based assay is essential to maintain the physiological context of the
components of the cellular pathways and the TF, thus accounting for any post-translational
modifications and changes in cellular localization. Post-translational processes such as
ubiquitination, phosphorylation, acetylation, and methylation can influence the net activity
of a signaling pathway and subsequent activation of a TF (Zhang and Reinberg, 2001). TF
activity also requires nuclear localization, as many TFs are found in the cytoplasm and
translocate upon activation. This regulation of TF activity by post-translational modification
or cellular compartmentalization cannot be directly assessed by techniques that quantify the
copy number of mRNA or proteins, such as microarray or proteomic techniques (Erfle et al.,
2007). In contrast, TF reporter vectors directly measure binding and transcriptional activity,
which results in the production of a reporter protein that can be easily measured. Normalized
for the extent of transfection, these reporter constructs have the ability to provide a
quantitative measure of TF activity. However, these constructs are typically applied on a
focused number of pathways, which provides only a limited view of the active signals within
the cell (Paech et al., 1997).
In this report, we describe a system that employs cell-based arrays for large-scale, rapid,
non-invasive, and quantitative analysis of TF activity. A two-plasmid system was employed,
with each position within the cell array receiving the same constitutively active
normalization plasmid encoding for Renilla luciferase and a distinct TF reporter vector
driving the expression of firefly luciferase. Luciferase levels were quantified by
bioluminescence imaging (BLI), which provides a high-throughput platform with rapid data
acquisition. BLI has accurately reported TF activity (Pannier et al., 2007), and this report
employs this technique to quantify the activity of multiple TFs in parallel. By eliminating
the need to lyse cells, BLI provided a non-invasive method of measuring luciferase levels
while preserving the viability of the cell population and removes a labor-intensive step
present in most traditional TF assays. Initial studies validated the measurement of multiple
TFs with BLI through correlation to values based on standard techniques using cell lysates.
Subsequent experiments measured the activity for 32 TFs and investigated the array-to-array
and day-to-day consistency of the system. Finally, the system was applied to capture the
differential TF activity profile during cell differentiation. The cellular array developed in
this report represents a robust and reliable method for the large-scale measurement of TF
activity that may ultimately be employed to investigate mechanisms of disease progression,
or identify targets for therapeutic intervention.
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Materials and Methods
Cells and Plasmids
The ER-positive MCF-7:WS8 mammary carcinoma cells, clonally derived from MCF-7
cells, were used for the study (Jiang et al., 1992). Cells were cultured in RPMI-1640 media
supplemented with 10% fetal bovine serum (FBS), 100 μM non-essential amino acids, 100U
antibiotics/antimycotic, 1 mM L-glutamine, and 6 ng/mL insulin and maintained at 37°C in a
humidified 5% CO2 atmosphere (Pannier et al., 2007). All media and media components
were purchased from Invitrogen (Carlsbad, CA). Plasmids were purified from bacteria
cultures using Qiagen (Valencia, CA) reagents and stored at −20°C in Tris–EDTA buffer.
TF-specific reporter plasmids were obtained from Panomics (Fremont, CA). The reporter
plasmids contain multiple copies of a cis-acting enhancer element containing TF-specific
binding sites that are located upstream of a minimal TATA box promoter (TA) driving the
expression of firefly luciferase. A second plasmid used for normalization contains a minimal
TA promoter driving the expression of Renilla luciferase (Ariazi et al., 2007).
Transfection in Plates
DNA complexes were formed following manufacturers instructions using Lipofectamine
LTX (Invitrogen) with a DNA/lipid ratio of 1:2 in serum-free Opti-MEM media. After 20
min, lipoplexes in volumes of 100 or 20 μL were added to 96- and 384-well plates,
respectively, to create a DNA concentration of 0.75 μg/well in a 96-well plate, and 0.075 μg/
well in a 384-well plate. The plates were incubated at 37°C for 2 h to allow for the
immobilization of complexes on the surface and facilitate a hybrid of surface and bolus
DNA delivery. During incubation, a cell suspension of MCF-7:WS8 cells was prepared in
2× supplemented media (RPMI-1640 with 20% FBS, 200 μM non-essential amino acids,
200 U antibiotics/antimycotic, 2 mM L-glutamine, and 12 ng/mL insulin). The cell solution
was added to the wells (for a total of 9 × 103 cells/well in the 384-well plate and 3.5 × 104
cells/well in the 96-well plate), and the plates were incubated for 24 h. Transfection
efficiency in 384- and 96-well plates was not significantly different (Supplementary Fig. 1).
Quantification of TF Activity by Lysis
Dual luciferase assays on cell lysates were performed to determine TF activity, which later
served as the reference to validate the BLI. Complexes containing TF-specific firefly
luciferase reporter plasmids and the Renilla luciferase normalization plasmid in a 3:1 ratio
were formed and deposited into a 96-well plate as described in the previous section. Twenty-
four hours after transfection, cells were harvested, lysed, and assayed for firefly and Renilla
luciferase activity using the Dual-Luciferase Reporter assay system (Promega, Madison,
WI). The dual-luciferase assays were carried out using BioTek® Synergy™ two multi-mode
microplate reader. Each TF activity experiment contained a TA vector control that acted as a
negative control. The TA vector control is a plasmid encoding for firefly luciferase driven
by a minimal TA promoter and lacking a TF-specific enhancer element along with the
Renilla normalization plasmid. The lysed cell relative ratio was calculated by dividing the
firefly luciferase luminescence signal by the Renilla signal followed by normalization to the
ratio of firefly to Renilla luciferase of the TA vector control.
Quantification of TF Activity by BLI
TF binding activity was also measured using live cell BLI within 384-well plates. TF
activity arrays were formed as previously described using TF-specific firefly luciferase
reporter plasmids and the Renilla luciferase normalization plasmid in a 3:1 ratio within 384-
well plates. Arrays were analyzed for TF activity by imaging at 24 h after transfection. Prior
to imaging, the plates and all reagents were warmed to 37°C. To image the Renilla activity,
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the substrate ViviRen (Promega) was first diluted to 100 μM in serum containing media and
then added to each well to achieve a final concentration of 20 μM. The light flux was
captured at 5 min after substrate addition with an exposure time of 1 min. Immediately
following Renilla signal image acquisition, the firefly luciferase substrate D-luciferin
(Molecular Therapeutics, Inc., Ann Arbor, MI, 5 mM in PBS) was added to each well to
achieve a final concentration of 1 mM D-luciferin per well. The plate was then imaged again
6 min after D-luciferin addition for a total exposure time of 1 min. Light emission from the
array was quantified using an IVIS imaging system (Xenogen Corp., Alameda, CA). The
activity from BLI is referred to as the normalized TF activity, was calculated by dividing the
firefly luciferase luminescence signal by the Renilla signal, and normalized to the ratio of
firefly luciferase to Renilla luciferase of the TA vector control. Prior to quantitative analysis
of BLI results, we validated that there was negligible crossing of the luminescence signal
between wells. Empty wells positioned next to wells with luminescence that exceeded the
maximal values for our system had 98.0 ± 0.5% lower photon emissions and were not
statistically different from the Renilla substrate background.
PMA Stimulation
Phorbol-12-myristate-13-acetate (PMA) was used to stimulate multiple signal transduction
pathways. The MCF-7:WS8 cells used in the induction experiments were cultured in
estrogen-free media (substituting phenol red-free RPMI-1740 and dextran-coated charcoal-
stripped FBS in the media) for 3 days prior to the experiment. Live cell TF activity arrays
were formed as previously described. Eighteen hours after cell seeding, the culture media
were replaced with serum-free media containing 20 ng/mL PMA or serum-free media
containing the equivalent volume of vehicle control, 100% ethanol. Arrays were imaged as
previously described 6 h after the media change. For analysis, the results of two arrays from
each culture condition were pooled giving n equal to 8 for each TF.
Statistical Analysis
We have used two different methods to assess differences between conditions, across arrays,
and across experimental days: an empirical hierarchical Bayesian method (EHBM) and a
Monte Carlo bootstrap method (MCBM; Lonnstedt and Speed, 2002; Smyth, 2004).
Empirical Hierarchical Bayesian Method—The Renilla and the firefly photon flux for
each condition were compared to substrate background using a one-tailed two-sample t-test
(n = 4) to determine their significance level relative to background. Reporters that were
significantly above Renilla and firefly photon flux compared to the wells containing no
DNA were considered to be above the background level at a significant level, α = 0.05. TF
activity (ratio between firefly and the Renilla photon flux) was normalized to the
corresponding activity of the TA vector control. Normalized TF activity relative to the
control was transformed using a variance stabilization normalization (VSN) procedure
(Bolstad et al., 2003) to assure the independence of the mean and the variance of the
measurement.
We employed an empirical hierarchical model developed by Lonnstedt and Speed (2002)
with empirical Bayesian hyperparameters that are calculated using Smyth’s method (2004).
Normality of the individual TF was confirmed by Shapiro’s test and the homogeneity of
variance by the Bartlett and Flinger methods independently. EBHM was employed to (a)
assess that the normalized TF activity was above the TA vector control activity, (b)
determine the differences between arrays, and (c) compare the effect of the treatment in the
TF activities of the cell. The EBHM has two main assumptions: (a) measurements of activity
for individual TFs are normal or approximately normal and (b) the variance and the mean of
each sample are independent. Analysis of the normalized TF activity was analyzed to
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determine if the mean and variance of all experiments were highly correlated
(Supplementary Fig. 2). The independence of the mean and the variance is assured by the
VSN transformation. The mean and variance of all the experiments are highly correlated.
The normality of each individual TF for all the arrays is determined using a Shapiro test,
after the corresponding transformation. All the TFs are normal, with a few exceptions that
may be due to outliers as the non-normality of the identified TFs do not occur in all the
experiments and conditions. The data of all the experiments have homogeneity of variance
according to the Bartlet and Flinger (data not shown). Therefore, EBHM might be employed
to analyze the results from the array experiments.
Array reproducibility was established by array correlations and by an EBHM. Array
correlations were performed using linear regression between all the normalized TF activities
relative to the control. An EBHM was used to compare the individual normalized TF
activity relative to the control between pairs of arrays. All the comparisons of the individual
moderated t-tests are summarized by a moderated F-test. The final P-values are corrected by
the false discovery rate (FDR) procedure (Benjamini et al., 2001) to reduce the number of
false positives. Results from the same condition performed in multiple experiments were
combined using a modified meta-analysis procedure (Zaykin et al., 2002). Note that only the
repeats with the same directionality are group together to avoid false positives. A more
conservative method (Pyne et al., 2006) based on a corrected significant level, α′, is also
presented to further reduce the presence of false positives. α′ is defined as α′ = α2/4L2,where
α is the original significant level and L is the number of experiments to be combined.
Monte Carlo Bootstrap—As a complement to the above-mentioned analysis, a more
rigorous resampling-based inference method was also used to analyze the array. Unlike
parametric tests, MCBM is not sensitive to assumptions of normality (Efron and Tibshirani,
1993). MCBM was used for comparison of the live cell relative ratio for each TF condition
to the TA vector control, across arrays and across experiments (Do and Hall, 1991; Hall and
Wilson, 1991). For multiple comparisons across arrays within an experiment, the average
mean difference of the normalized TF activity was calculated and used as the test statistic to
quantify differences between arrays. The significance of the statistic was assessed using the
bootstrap method where the distribution of the statistic under the null hypothesis was
estimated by 10,000 cycles of Monte Carlo simulations of sampling with replacement of the
pooled values for the live cell relative ratio from all arrays, and calculating values for the
average delta mean. Significance for the array-to-array and day-to-day comparison was
assessed by counting the number of P-values for the individual conditions that were less
than α and using the binomial distribution to calculate how likely this count is under the null
hypothesis. To account for multiple comparisons, the FDR approach was used to modify α
and ensure the probability of false positives to be <5% (Benjamini and Hochberg, 1995;
Saville, 1990).
Results
Analysis of TF Activity Assay
Lysed cell assays, the standard approach to luciferase assays, were initially performed to
quantify the activities of six TFs through delivery of TF reporter plasmids. Lipoplexes were
deposited in 96-well plates to transfect MCF7:WS8 cells and report on the activities of AP1,
ER, NFκB, SP1, E2F1, and GATA3 in conjunction with the Renilla luciferase normalization
plasmid. Relative to the TA vector control, which lacks the specific TF binding site, the
lysed cell relative ratio of AP1, ER, NFκB, SP1, and E2F1 was all significantly increased
(Fig. 1). The dual plasmid system normalized for transfection variability and produced
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quantitative measurements of the TF activity for the six TFs. The TF activity profile
provided a reference for the analysis of TF activity using BLI.
BLI following dual plasmid delivery was subsequently investigated for rapid, non-invasive
data acquisition. This imaging approach minimizes post-transfection processing, which
reduces variability and facilitates the use of smaller well formats that can reduce reagent
usage by one-tenth. Cell arrays were produced using the same six TF reporter plasmids
employed for quantification by cell lysis. The transfected cell arrays were imaged and values
for photon flux were determined for Renilla (Fig. 2a and b) and firefly luciferase (Fig. 2c
and d). All wells had Renilla luciferase expression significantly above the substrate
background of a control without DNA, indicating substantial transfection within each well.
The raw output for the photon emission for firefly luciferase (Fig. 2d) was divided by the
photon emission from Renilla luciferase (Fig. 2b) to normalize light emission. This
normalized light emission for each TF was divided by the light emission from the TA vector
control condition to produce the normalized TF activity (Fig. 2e). Relative to the TA control,
the normalized activity was significantly increased for AP1, ER, NFκB, SP1, and E2F1. The
normalized TF activities measured by the lysed and live cell assays identified the same TFs
as being significantly active and were highly correlated (Fig. 2f, R2 = 0.999). BLI was thus
used for all subsequent arrays.
Large-Scale TF Activity Analysis
The array was subsequently expanded to quantify the activity for a larger library of plasmids
and the array was evaluated for repeatability and robustness. Arrays with 32 TF activity
reporter plasmids (Supplementary Table I) and 2 internal controls were formed within a 384-
well plate with four replicates of each condition. A total of six arrays were formed and
imaged in two independent experiments, and the resulting TF activity profiles were analyzed
to determine the TFs with activity above the TA vector control, the consistency between
arrays, and the consistency between days. To reduce false negatives resulting from poor
transfection, wells that do not have a photon flux above the substrate background, either
Renilla or firefly luciferase, were excluded from analysis. The Renilla and firefly luciferase
light emissions of the reporter genes were significantly above the substrate background for
98% of wells (Fig. 3a and b) indicating consistently sufficient levels of transfection.
Analysis of the multiple arrays formed on different days indicated that the TF activity arrays
had high reproducibility, with correlation coefficients ≥0.95 (Fig. 3c). A Bayesian analysis
and an MCBM similarly indicated no significant difference between arrays within an
experiment or between experiments (Supplementary Tables II and III), further confirming
reproducibility of results and demonstrating the independence of the method of analysis.
Active TFs within the cell were identified by comparing the normalized TF activity and the
normalized TA vector control. At a highly conservative alpha (α′ = 0.00015), the Bayesian
method identified seven TFs (AP1, CRE, ER, HIF-1, NFκB, p53, and SP1) with activities
greater than the TA vector control (Fig. 4 and Table I). However, with more relaxed
constraints the array identified two additional TFs with activity over control (GATA4 and
E2F1). Monte Carlo methods confirmed the results of the Bayesian methods (Supplementary
Table IV).
Identification of Changes in TF Activity
The potential of the array to detect changes in the TF activity profile was subsequently
investigated by performing cultures with and without PMA stimulation, which inhibits
proliferation within MCF-7:WS8 cells, resulting from a specific block within the G1 cell-
cycle phase to induce a more differentiated phenotype (Guilbaud et al., 1990; Valette et al.,
1987). Five TFs (SRF, CRE, NFκB, AP1, and p53) had significant changes in activity upon
PMA treatment (20 ng/mL) relative to the vehicle control (Fig. 5 and Supplementary Table
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IV). As expected, several of the differentially activated TFs have been reported to play key
roles in modulation of cell cycle, and cellular differentiation and proliferation. The activity
of p53, a tumor suppressor protein, is reduced with PMA and activities of SRF, CRE, AP1,
and NFκB were all increased with PMA treatment; these observations are consistent with the
previously published data (Abdel-Mageed and Agrawal, 1998; Adiseshaiah et al., 2005;
Bale and Dorsa, 1998; Garcia-Rodriguez and Rao, 1998; Guilbaud et al., 1990; Hermanson
et al., 2002; Hill et al., 1994; Liu et al., 1999; Ma et al., 2009; Siebenlist et al., 1994).
Discussion
This report presents a system for rapid, non-invasive, and large-scale quantification of the
activities of TFs using a combination of gene delivery of TF reporter constructs and BLI. A
critical distinction of this system is that the measurement of TF activity within the cell can
indicate that the signaling pathways upstream of the TF are active, and that the effectors
within the pathway are present in the appropriate compartments and have undergone the
necessary post-translational modifications. While genomics and proteomics approaches are
being employed to infer pathway activity (Hoheisel, 2006), this inference is hindered by the
complexity of promoter regions on genes, assumptions that mRNA and protein levels
correlate to activity, and is computationally intensive. Rather than inferring activity, the
cellular arrays reported herein directly measured TF activity with great sensitivity and
minimal variability. Importantly, we applied this technology for simultaneous, large-scale
analysis of TF activity, which can capture the breadth of active pathways within the cell.
This technology combines parallel transient transfection, BLI, and the use of luciferase
reporter vectors to quantify TF activity. Large-scale pathway activity has previously been
investigated by creating cell lines stably expressing a GFP reporter construct, which required
both the generation and maintenance of multiple cell lines (King et al., 2007). By using
transient transfection, the array presented herein may increase the flexibility of the system
by allowing for the application of the array to any easily transfected cell line. Difficult to
transfect cell lines or primary cells may require viral vectors to determine the TF activity
profile. Relative to fluorescence imaging, BLI has the potential for substantially lower and
more consistent background, which could provide for greater sensitivity. Finally, the
reporter gene luciferase provides signal amplification by virtue of its enzymatic activity,
which may also increase sensitivity.
The TF activity array employs parallel gene delivery for the determination of TF activity,
with two constructs delivered to enable quantitative analysis. The inclusion of the Renilla
luciferase normalization vector within each condition allows normalization of the firefly TF
reporter signal to account for varying transfection and can identify wells with insufficient
transfection that can be removed from analysis, thus reducing false positives. Importantly,
all plasmids within the array contain the same minimal TA promoter, which is also
important for proper normalization and should allow for comparisons between multiple cell
lines. The TF activity profile of MCF7:WS8 cells was analyzed using statistical techniques
common to microarray analysis and also non-parametric resampling-based inference
methods, both of which supported the reproducibility of the system not only between arrays
but also across experimental days. This consistency in array output is beneficial for reducing
the number of experiments and minimizing false positives and negatives common to large-
scale analysis of biological processes. The potential for false positives and negatives must be
evaluated within any large-scale assay. For the statistical analysis of the array, methods that
reduce the risk for false positives were chosen, knowing that this may increase the risk of
false negatives. False negatives can occur for TFs that produce luminescence that is near
background for the substrate. This luminescence assay is not as sensitive as some protein
binding methods, such as electrophoresis mobility shift assay or chromatin
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immunoprecipitation. Consequently, the strength of the array is identifying multiple TF that
are active (i.e., positive) rather than ones that are not (i.e., negative). Consistent with other
high-throughput approaches (e.g., microarrays), results of the array must be validated before
drawing conclusions about the biological system. The identification of false negatives is
challenging for most high-throughput technologies, including microarrays. In this report, the
array determined that 7 of 32 (22%) TFs were significantly active within the MCF7:WS8
cells (in basal media conditions). The TFs identified are known for their roles in cell-cycle
regulation, differentiation, cell survival, apoptosis, and differentiation, and therefore are of
interest in the study of cancer cells. Many TFs are not universally expressed or only respond
to specific stimuli, which was consistent with our results that only a fraction of the TFs had
activity above background under basal conditions. Transfection can stimulate pathways
associated with inflammation, which can activate the associated TFs. This stimulation of
these pathways by transfection must be considered when analyzing the cellular response.
The array also captured the TFs with altered activity in response to a factor that induces
differentiation of MCF-7 cells (Guilbaud et al., 1990; Valette et al., 1987). Pharmacological
activators such as PMA are commonly used to target individual signaling pathways, yet the
broad impact of these small molecules on the signaling network, has not been well
characterized. The TF activity array identified four TFs (AP1, CRE, NFκB, SRF) with
increased activity and one TF with decreased activity (p53) at 6 h after PMA stimulation.
These TFs have previously been linked to PMA activation individually (Abdel-Mageed and
Agrawal, 1998; Adiseshaiah et al., 2005; Bale and Dorsa, 1998; Garcia-Rodriguez and Rao,
1998; Guilbaud et al., 1990; Hermanson et al., 2002; Hill et al., 1994; Liu et al., 1999; Ma et
al., 2009), yet the ability to capture changes associated with several pathways in a single
experiment represents the power of the TF activity array. This ability to measure the
response of numerous TFs will enable fundamental studies, such as the specificity of drug
actions or mechanisms of drug resistance to identify the regulatory processes that are
differentially active between normal and disease phenotypes.
BLI of luciferase expression was the enabling tool for large-scale analysis of TF activity.
Previously, Romanov et al. (2008) had employed reporter constructs with specific
processing tags that, upon amplification, enabled quantification of transcript levels by
capillary electrophoresis. Herein, we combined BLI with the reporter protein luciferase,
which provides great sensitivity as a result of enzymatic amplification, allowing detection of
TFs with low activity (Corish and Tyler-Smith, 1999; Ignowski and Schaffer, 2004). Live
cell BLI captured the output of all wells simultaneously, rather than sequentially as with
microplate readers that measure one well at a time, allowing for rapid data acquisition by
eliminating the need for the cell lysis step. Relative to approaches based on cell lysis, the
ability to monitor TF activity by BLI may enable TF profiles to be determined dynamically
within the same cell population in a single well of the array. The imaging of both Renilla
and firefly luciferase within a single array can be accomplished in approximately 16 min,
which includes time for substrate addition and incubation, plate loading, and imaging, and
dynamic imaging would need to account for this manipulation of the plate. Importantly, we
demonstrated that BLI of TF activity produced results that are highly correlated with
standard lysed cell assays. The rapid data acquisition combined with minimal post-
transfection processing enabled by BLI will ultimately enable extension of the array to a
larger library of reporter constructs. Since array-to-array variability is low, the number of
reporter constructs analyzed with this approach is not expected to be limiting.
In summary, we report a dual-plasmid TF activity array to provide a rapid, non-invasive,
large-scale quantification of TF activity that can detect the impact of perturbations to the
culture environment. BLI produces comparable results to the traditional cell lysis approach,
yet requires less handling of the sample is rapid and thus has relatively low data acquisition
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time. Furthermore, this method allows for a smaller plate format thus requiring fewer cells
and can be employed to monitor numerous wells simultaneously. The activities of 32 TFs
were assessed and the outputs of multiple arrays in different experiments were consistent
and reproducible between arrays and experimental day. Finally, the array captured changes
in the TF activity profile of MCF-7:WS8 breast cancer cells initiated by PMA activation.
The TF activity array was able to monitor changes in multiple pathways in parallel, allowing
for broad analysis of the overall interplay of signaling within the cells. Ultimately,
transfected cell arrays have the potential to provide a rapid characterization of TF activity
profiles of different cellular phenotypes and to detect alterations in TF activity within a
changing environment. This system, which can connect environmental changes to TF
activity patterns, may be a fundamental tool to investigate molecular mechanisms
underlying diseases such as cancer and may provide a means to identify signaling pathways
that could be targeted for therapeutic intervention.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Dual-luciferase reporter assay to measure TF activity. MCF-7:WS8 cells were transfected in
parallel with reporter constructs containing enhancer elements for specific TFs (AP1, ER,
NFκB, SP1, E2F1, and GATA3) and TA vector control in combination with a Renilla
luciferase reporter to normalize for transfection. Cells were lysed 24 h after transfection and
TF activitywas quantified using a dual-luciferase assay. Values are means ± SD of three
independent experiments done in triplicate.
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Figure 2.
Dual-luciferase reporter constructs to measure TF activity. Dual-luciferase levels were
analyzed using bioluminescence imaging 24 h after transfection by first imaging for Renilla
luciferase (a and b) and then imaging each array for firefly luciferase (c and d). a and c:
Pseudo-color mapping of photon flux localized within wells of the array were quantified to
determine average photon fluxes for each well (b and d). e: The raw output for the firefly
photon flux of each well was normalized by the photon emission from Renilla luciferase to
produce the normalized light emission. f: The TF activity profile for MCF7:WS8 cells using
lysed and live cell assays were directly compared using linear regression. The TF activity
results were highly correlated (R2 = 0.999). [Color figure can be seen in the online version
of this article, available at wileyonlinelibrary.com.]
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Figure 3.
Transfected cell array for the large-scale analysis of the activity of 32 TFs using BLI.
Pseudo-colored image of light emission within wells of a 384-well plate upon subsequent
addition of substrates for Renilla luciferase (a) and firefly luciferase (b). c: Linear regression
comparison between arrays within and across experiments. TF activity profiles between six
arrays formed in two independent experiments are highly correlated within experiments
(blue comparisons) and across experiments (green comparisons) with a minimum correlation
coefficient of 0.95. [Color figure can be seen in the online version of this article, available at
wileyonlinelibrary.com.]
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Figure 4.
Transfected cell array for the large-scale analysis of the activity of 32 TFs using BLI. The
normalized TF activity profile identified seven TFs with activities significantly higher than
the TA vector control.
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Figure 5.
Changes in normalized TF activity profile of MCF7 cells upon induction with PMA. Of the
32 TFs in the array, 5 TFs had differential activity in response to PMA treatment, 4 TFs had
increased activity upon PMA induction over vehicle delivery, SRF (+124%), CRE (+73%),
NFκB (+38%), and AP1 (+39%), and 1 TF decreased in activity as compared to vehicle
delivery (−26%).
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Table I
Summary of normalized TF activity for large-scale activity array and statistical significance.
TF
TF activity
P-valueAverage Standard deviation
Control 1.000 0.074 1
p53 7.487 1.214 1.79E−92
AP1 2.620 0.280 1.69E−65
CRE 1.442 0.150 5.54E−24
HIF-1 1.307 0.094 2.61E−19
NFκB 1.291 0.106 8.13E−18
ER 1.284 0.135 4.57E−13
SP1 1.259 0.138 1.27E−11
GATA4 1.144 0.078 2.03E−04
SRF 1.107 0.116 1.04E−01
E2F1 1.101 0.151 1.85E−02
AP2 1.085 0.117 1.00E+00
AP4 1.071 0.110 1.00E+00
GATA 1.047 0.089 1.00E+00
IRF-1 1.045 0.049 1.00E+00
SRE 1.044 0.150 1.00E+00
VDR 1.034 0.082 1.00E+00
GAS 1.030 0.083 1.00E+00
NFAT 1.018 0.112 1.00E+00
GATA1/2 1.017 0.082 1.00E+00
Smad 3/4 1.016 0.110 1.00E+00
YY1 1.013 0.090 1.00E+00
AR 0.991 0.072 1.00E+00
AP3 0.988 0.089 1.00E+00
GR 0.986 0.082 1.00E+00
PR 0.977 0.132 1.00E+00
HSE 0.977 0.068 1.00E+00
Smad 0.976 0.111 1.00E+00
MEF-3 0.973 0.092 1.00E+00
MEF-2 0.970 0.077 1.00E+00
MEF-1 0.957 0.063 1.00E+00
STAT4 0.950 0.076 1.00E+00
GATA3 0.950 0.083 1.00E+00
TFs in bold are considered to have statistically significant higher activity than the TA vector control using Bayesian-based comparisons and an
FDR corrected α′ = 0.00015.
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